Schedule 13G ownership disclosure

ADAGIO MED HLDGS INC

Common Stock, $0.0001 par value per share · CUSIP: 00534B100

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Perceptive Advisors LLC

    Shares: 15,321,655 · Class: 73.6%

  • Joseph Edelman

    Shares: 15,321,655 · Class: 73.6%

  • Perceptive Life Sciences Master Fund, Ltd.

    Shares: 15,120,753 · Class: 72.6%

  • C2 Life Sciences LLC

    Shares: 200,902 · Class: 1%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021216
Form type
SCHEDULE 13G/A
Filer
Adagio Medical Holdings, Inc.
CIK
CIK 2006986
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub